Because 1H MRS can be broadly used in cancer patients [29], our study indicates that such radiologic image-based monitoring should prove effective in lymphoma patients treated with a BTK inhibitor and, by extension, in patients with other malignancies treated with analogous kinase inhibitors. This evidence concerns the gene BTK and cancer.